Skip to main content
Log in

Rolle der Radiotherapie beim Neuroblastom

Lokale Kontrolle und Rezidivmuster nach Radiotherapie für Hochrisikopatienten in den Therapiestudien NB97 und NB2004HR – eine Studie der Jungen DEGRO

The role of radiotherapy in neuroblastoma

Local control and pattern of relapse after radiotherapy for high-risk patients enrolled in the NB97 and NB2004HR trials—a Young DEGRO study

Forum Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions


  1. Berthold F, Spix C, Kaatsch P, Lampert F (2017) Incidence, survival, and treatment of localized and metastatic neuroblastoma in Germany 1979–2015. Paediatr Drugs 19:577–593.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L et al (2016) Neuroblastoma. Nat Rev Dis Primer 2:16078.

    Article  Google Scholar 

  3. Boterberg T (2020) Radiotherapy for neuroblastoma. In: Sarnacki S, Pio L (Hrsg) Neuroblastoma Clin. Surg. Manag. Springer, Cham, S 163–170

    Chapter  Google Scholar 

  4. Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27:289–297.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jazmati D, Butzer S, Hero B, Khalil AD, Merta J, Bäumer C et al (2020) Proton beam therapy for children with neuroblastoma: experiences from the prospective Kiproreg registry. Front Oncol 10:617506.

    Article  PubMed  Google Scholar 

  6. AWMF Zugegriffen: 24. Apr. 2020

  7. Tas ML, Reedijk AMJ, Karim-Kos HE, Kremer LCM, van de Ven CP, Dierselhuis MP et al (2020) Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma. Eur J Cancer 124:47–55. .2019.09.025

    Article  CAS  Google Scholar 

  8. Arumugam S, Manning-Cork NJ, Gains JE, Boterberg T, Gaze MN (2018) The evidence for external beam radiotherapy in high-risk neuroblastoma of childhood: a systematic review. Clin Oncol.

    Article  Google Scholar 

  9. Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Ash S et al (2020) Investigation of the role of Dinutuximab beta-based immunotherapy in the SIOPEN high-risk neuroblastoma 1 trial (HR-NBL1). Cancers.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu KX, Naranjo A, Zhang FF, DuBois SG, Braunstein SE, Voss SD et al (2020) Prospective evaluation of radiation dose escalation in patients with high-risk neuroblastoma and gross residual disease after surgery: a report from the children’s oncology group ANBL0532 study. J Clin Oncol.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Berthold F, Faldum A, Ernst A, Boos J, Dilloo D, Eggert A et al (2020) Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann Oncol 31:422–429.

    Article  CAS  PubMed  Google Scholar 

  12. Jazmati D, Butzer S, Hero B, Doyen J, Khalil AD, Steinmeier T et al (2020) Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004. Strahlenther Onkol.

    Article  PubMed  Google Scholar 

  13. Ducassou A, Gambart M, Munzer C, Padovani L, Carrie C, Haas-Kogan D, et al (2015) Long-term side effects of radiotherapy for pediatric localized neuroblastoma. Strahlenther Onkol 191(7):604–612.

    Article  PubMed  Google Scholar 

  14. Gaze MN, Boterberg T, Dieckmann K, Hörmann M, Gains JE, Sullivan KP et al (2013) Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group’s High-risk Neuroblastoma Trial: a SIOPEN study. Int J Radiat Oncol Biol Phys 85:170–174.

    Article  PubMed  Google Scholar 

  15. Gaze MN, Boterberg T, Dieckmann K, Habrand J‑L, Helfré S, Peylan-Ramu N et al (2010) Development of an electronic database for quality assurance of radiotherapy in the International Society of Paediatric Oncology (Europe) high risk neuroblastoma study. Radiother Oncol 97:593–595.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Danny Jazmati.

Ethics declarations


D. Jazmati, M. Oertel, L. Käsmann, S. Ziegler, T. Simon und B. Timmermann geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jazmati, D., Oertel, M., Käsmann, L. et al. Rolle der Radiotherapie beim Neuroblastom. Forum 36, 256–259 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI: